AAAAAA

   
Results: 1-12 |
Results: 12
Targeting tumor necrosis factor alpha - New drugs used to modulate inflammatory diseases
Authors: LaDuca, JR Gaspari, AA
Citation: Jr. Laduca et Aa. Gaspari, Targeting tumor necrosis factor alpha - New drugs used to modulate inflammatory diseases, DERM CLIN, 19(4), 2001, pp. 617
Cutaneous drug reactions
Authors: Svensson, CK Cowen, EW Gaspari, AA
Citation: Ck. Svensson et al., Cutaneous drug reactions, PHARM REV, 53(3), 2001, pp. 357-379
Recombinant human antibody single chain variable fragments reactive with Candida albicans surface antigens
Authors: Haidaris, CG Malone, J Sherill, LA Bliss, JM Gaspari, AA Insel, RA Sullivan, MA
Citation: Cg. Haidaris et al., Recombinant human antibody single chain variable fragments reactive with Candida albicans surface antigens, J IMMUNOL M, 257(1-2), 2001, pp. 185-202
Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept - A recombinant tumor necrosis factor alpha receptor: Fc fusion protein
Authors: Zeltser, R Valle, L Tanck, C Holyst, MM Ritchlin, C Gaspari, AA
Citation: R. Zeltser et al., Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept - A recombinant tumor necrosis factor alpha receptor: Fc fusion protein, ARCH DERMAT, 137(7), 2001, pp. 893-899
The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans' cells
Authors: Burns, RP Ferbel, B Tomai, M Miller, R Gaspari, AA
Citation: Rp. Burns et al., The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans' cells, CLIN IMMUNO, 94(1), 2000, pp. 13-23
Dermatologic changes associated with roquinimex immunotherapy after autologous bone marrow transplant
Authors: Ohsuga, Y Rowe, JM Liesveld, J Burns, RP Gaspari, AA
Citation: Y. Ohsuga et al., Dermatologic changes associated with roquinimex immunotherapy after autologous bone marrow transplant, J AM ACAD D, 43(3), 2000, pp. 437-441
Allergens and irritants transcriptionally upregulate CD80 gene expression in human keratinocytes
Authors: Wakem, P Burns, RP Ramirez, F Zlotnick, D Ferbel, B Haidaris, CG Gaspari, AA
Citation: P. Wakem et al., Allergens and irritants transcriptionally upregulate CD80 gene expression in human keratinocytes, J INVES DER, 114(6), 2000, pp. 1085-1092
Minocycline-induced hyperpigmentation in patients with pemphigus and pemphigoid
Authors: Ozog, DM Gogstetter, DS Scott, G Gaspari, AA
Citation: Dm. Ozog et al., Minocycline-induced hyperpigmentation in patients with pemphigus and pemphigoid, ARCH DERMAT, 136(9), 2000, pp. 1133-1138
Mechanisms of allergic and irritant contact dermatitis
Authors: Wakem, P Gaspari, AA
Citation: P. Wakem et Aa. Gaspari, Mechanisms of allergic and irritant contact dermatitis, BIOCHEMICAL MODULATION OF SKIN REACTIONS, 2000, pp. 83-106
B7-1 overexpression by thymic epithelial cells results in transient and long-lasting effects on thymocytes and peripheral T helper cells but does notresult in immunodeficiency
Authors: Burns, RP Nasir, A Haake, AR Barth, RK Gaspari, AA
Citation: Rp. Burns et al., B7-1 overexpression by thymic epithelial cells results in transient and long-lasting effects on thymocytes and peripheral T helper cells but does notresult in immunodeficiency, CELL IMMUN, 194(2), 1999, pp. 162-177
American experience with low-dose thalidomide therapy for severe cutaneouslupus erythematosus
Authors: Duong, DJ Spigel, GT Moxley, RT Gaspari, AA
Citation: Dj. Duong et al., American experience with low-dose thalidomide therapy for severe cutaneouslupus erythematosus, ARCH DERMAT, 135(9), 1999, pp. 1079-1087
Advances in laboratory evaluation of pemphigus vulgaris
Authors: Gaspari, AA
Citation: Aa. Gaspari, Advances in laboratory evaluation of pemphigus vulgaris, ARCH DERMAT, 135(11), 1999, pp. 1418-1418
Risultati: 1-12 |